Breast cancer is the most frequent
malignancy among women. Since genetic factors such as BRCA1 and BRCA2 as well as reproductive history constitute only 30% of the cause, environmental exposure may play a significant role in the development of
breast cancer. Likewise, the relevant
enzymes involved in the biotransformation of
xenobiotics (from tobacco
smoke, diet or other environmental sources) might play a role in breast
carcinogenesis. Since individuals with modified ability to metabolize these
carcinogens could have a different risk for
breast cancer, we investigated the role of
cytochromes P-450 (
CYP1A1,
CYP2D6),
glutathione-S-
transferases (GSTM1, GSTT1, GSTP1) and N-
acetyltransferases (NAT1, NAT2) gene variants in breast
carcinogenesis. A case-control study was conducted on 149 women with
breast carcinoma and 207 healthy controls, both of French-Canadian origin. The
CYP1A1*4 allele was found to be a significant risk determinant of
breast carcinoma (OR = 3.3, 95% CI 1.1-9.7), particularly among post-menopausal women (OR = 4.0, 95% CI 1.2-13.8). The frequency of NAT2 rapid acetylators was increased among smokers (OR = 2.6, 95% CI 0.8-8.2), while the NAT1*10 allele conferred a 4-fold increase in risk among women who consumed well-done meat (OR = 4.4, 95% CI 1.0-18.9). These data suggest that
CYP1A1*4, NAT1 and NAT2 variants are involved in the susceptibility to
breast carcinoma by modifying the impact of exogenous and/or endogenous exposures.